open access

Vol 8, No 4 (2004)
Prace oryginalne
Published online: 2004-07-22
Get Citation

Evaluation of urine endothelin-1 (ET-1) level in patients with essential hypertension

Teresa Kosicka, Hanna Kara-Perz, Jerzy Głuszek
Nadciśnienie tętnicze 2004;8(4):239-243.

open access

Vol 8, No 4 (2004)
Prace oryginalne
Published online: 2004-07-22

Abstract

Background Endothelin-1 (ET-1) as the most potent vasoconstrictor substance may play an important role in pathogenesis of arterial hypertension. These biological effects of ET-1 may indicate the logical relationship between increased ET-1 concentration and the presence of systemic hypertension. Researches do not reveal reliable information about plasma ET-1 levels in hypertensive patients. On the base of these data we may suspect that evaluation of ET-1 concentration in urine (beside cell culture) may be more precise that evaluation of this peptide in the plasma.
The aim of our study was to estimate the diagnostic value of plasma and urine ET-1 concentration measurement in hypertensive patients.
Material and methods Two groups were studied: group I - 26 hypertensive patients (systolic blood pressure: Me 158 ± 9 mm Hg, diastolic blood pressure: Me 95 ± 5 mm Hg) and group II - 10 healthy volunteers (systolic blood pressure: 120 ± 4,00 mm Hg, diastolic blood pressure: Me 68 ± 4,50 mm Hg). In classifying subjects ET-1 concentrations were measured by radioimmunoassay in: a) plasma, b) 24-hour urine collection.
Results 1. Plasma ET-1 concentration did not differ between the two groups (Me ± S group I: 37,4 ± 11,4 vs. group II: 33,3 ± 6,66 pg/ml, NS). 2. Urine ET-1 excretion assessed in 24-hour urine collection were significantly higher in I group than in II group (Me ± S group I: 106,11 ± 49,74 vs. group II: 11,3 ± 6,65 ng/g urinary creatinine, p = 0.00001).
Conclusions We may suspect that evaluation of ET-1 concentration in 24-hour urine collection may be more exact than evaluation of this peptide in plasma. This observation may prove the importance of ET-1 in hypertension.

Abstract

Background Endothelin-1 (ET-1) as the most potent vasoconstrictor substance may play an important role in pathogenesis of arterial hypertension. These biological effects of ET-1 may indicate the logical relationship between increased ET-1 concentration and the presence of systemic hypertension. Researches do not reveal reliable information about plasma ET-1 levels in hypertensive patients. On the base of these data we may suspect that evaluation of ET-1 concentration in urine (beside cell culture) may be more precise that evaluation of this peptide in the plasma.
The aim of our study was to estimate the diagnostic value of plasma and urine ET-1 concentration measurement in hypertensive patients.
Material and methods Two groups were studied: group I - 26 hypertensive patients (systolic blood pressure: Me 158 ± 9 mm Hg, diastolic blood pressure: Me 95 ± 5 mm Hg) and group II - 10 healthy volunteers (systolic blood pressure: 120 ± 4,00 mm Hg, diastolic blood pressure: Me 68 ± 4,50 mm Hg). In classifying subjects ET-1 concentrations were measured by radioimmunoassay in: a) plasma, b) 24-hour urine collection.
Results 1. Plasma ET-1 concentration did not differ between the two groups (Me ± S group I: 37,4 ± 11,4 vs. group II: 33,3 ± 6,66 pg/ml, NS). 2. Urine ET-1 excretion assessed in 24-hour urine collection were significantly higher in I group than in II group (Me ± S group I: 106,11 ± 49,74 vs. group II: 11,3 ± 6,65 ng/g urinary creatinine, p = 0.00001).
Conclusions We may suspect that evaluation of ET-1 concentration in 24-hour urine collection may be more exact than evaluation of this peptide in plasma. This observation may prove the importance of ET-1 in hypertension.
Get Citation

Keywords

plasma endothelin-1; essential hypertension; urine endothelin-1

About this article
Title

Evaluation of urine endothelin-1 (ET-1) level in patients with essential hypertension

Journal

Arterial Hypertension

Issue

Vol 8, No 4 (2004)

Pages

239-243

Published online

2004-07-22

Bibliographic record

Nadciśnienie tętnicze 2004;8(4):239-243.

Keywords

plasma endothelin-1
essential hypertension
urine endothelin-1

Authors

Teresa Kosicka
Hanna Kara-Perz
Jerzy Głuszek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl